Nintedanib 150mg

Nintedanib 150 mg is a tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and certain cancers. It works by blocking VEGF, FGF, and PDGF receptors, reducing fibrosis and slowing disease progression. Taken twice daily with food, it helps preserve lung function by inhibiting fibroblast proliferation. Common side effects include diarrhea, nausea, and liver enzyme elevation. Regular monitoring is needed to manage adverse effects and ensure safe treatment.